Current Opinion in Pharmacology, 1471-4892

Journal

1 - 10 out of 28Page size: 10

Publications

  1. 2013
  2. Published

    Interleukin-23: a promising therapeutic target in seronegative spondyloarthropathy.

    Jonathan Sherlock, Jun 2013, In: Current Opinion in Pharmacology. 13, 3, p. 445-448

    Research output: Contribution to journal › Article › peer-review

  3. Published

    New biologic therapy for systemic lupus erythematosus

    Caroline Gordon, Jun 2013, In: Current Opinion in Pharmacology. 13, 3, p. 405-12 8 p.

    Research output: Contribution to journal › Article › peer-review

  4. Published

    Right target, right place, right time: how understandings of pathogenic mechanisms are informing the treatment of rheumatic diseases

    Karim Raza & Christopher Buckley, Jun 2013, In: Current Opinion in Pharmacology. 13, 3, p. 402-404

    Research output: Contribution to journal › Editorial › peer-review

  5. Published

    Targeting 11β-hydroxysteroid dehydrogenases: a novel approach to manipulating local glucocorticoid levels with implications for rheumatic disease

    Rowan Hardy & Mark Cooper, Jun 2013, In: Current Opinion in Pharmacology. 13, 3, p. 440-4 5 p.

    Research output: Contribution to journal › Review article › peer-review

  6. Published

    The fibroblast as a therapeutic target in rheumatoid arthritis

    Andrew Filer, Jun 2013, In: Current Opinion in Pharmacology. 13, 3, p. 413-9 7 p.

    Research output: Contribution to journal › Article

  7. Published

    Heart failure therapy in patients with coronary artery disease

    Apr 2013, In: Current Opinion in Pharmacology. 13, 2, p. 205-9 5 p.

    Research output: Contribution to journal › Article › peer-review

  8. 2012
  9. Published

    T cell trafficking and metabolism: novel mechanisms and targets for immunomodulation

    Claudio Mauro, 1 Aug 2012, In: Current Opinion in Pharmacology. 12, 4, p. 452-457

    Research output: Contribution to journal › Review article › peer-review

  10. Published

    Biologics against cancer-specific receptors - challenges to personalised medicine from early trial results

    Dion Morton, 2012, In: Current Opinion in Pharmacology. 12, 4, p. 392-7 6 p.

    Research output: Contribution to journal › Article › peer-review

  11. 2011
  12. Published

    Bridging innate and adaptive immunity: removing the toll

    John Curnow & Graham Wallace, 1 Aug 2011, In: Current Opinion in Pharmacology. 11, 4, p. 395-396 2 p.

    Research output: Contribution to journal › Editorial

  13. Published

    5-HT: The promiscuous and happy hormone!

    Nicholas Barnes, 1 Feb 2011, In: Current Opinion in Pharmacology. 11, 1, p. 1-2 2 p.

    Research output: Contribution to journal › Article

Previous 1 2 3 Next